Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
30.0%
% of XPH's 40 holdings also in PPH
50.0%
% of PPH's 27 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 4.8% | 6.2% | 4.8% |
|
ELI LILLY & CO | 4.8% | 12.2% | 4.8% |
|
PFIZER INC | 4.6% | 4.5% | 4.5% |
|
JOHNSON & JOHNSON | 4.5% | 6.6% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% | 4.4% | 4.4% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PPH
|
INTRA-CELLULAR THERAPIES INC | 4.7% |
|
AXSOME THERAPEUTICS, INC. | 4.6% |
|
ROYALTY PHARMA PLC CLASS A | 4.5% |
 |
PERRIGO CO | 4.1% |
|
ORGANON & CO. | 3.9% |
|
CATALENT INC | 3.7% |
|
CORCEPT THERAPEUTICS INC | 3.6% |
|
JAZZ PHARMACEUTICALS PLC | 3.5% |
|
ELANCO ANIMAL HEALTH, INC. | 3.5% |
|
ARVINAS, INC. | 2.8% |
XPH Underweight Relative to PPH
 |
NOVO-NORDISK A/S-SPONS ADR | -9.5% |
|
ELI LILLY & CO | -7.4% |
|
ABBVIE INC | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.2% |
 |
NOVARTIS AG-ADR | -4.8% |
|
AMERISOURCEBERGEN CORP | -4.7% |
|
MCKESSON CORP | -4.7% |
 |
SANOFI-AVENTIS-ADR | -4.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.2% |